Again no agreement amongst Member States - Commission must now act
The GTF understands that Member States voted on the renewal of the EU approval for glyphosate during the Standing Committee meeting of November 9th, but that a QMV in favour of the Commission’s proposal was not reached.
At this stage, the failure to renew of the approval of glyphosate by Member States represents an unprecedented delay compared to the standard timeframe and applicable EU framework for the re-approval of active substances. The present delay comes on top of the decision to extend the authorisation of glyphosate by 18 months in June 2016 to allow an extraordinary review by the European Chemicals Agency (ECHA). It also follows two revisions to the latest Commission proposal announced in July.
The comprehensive risk assessments conducted by the BfR, EFSA and ECHA clearly concluded that glyphosate poses no unacceptable risks. Therefore, delays of this nature which are evident during the final stages of the process simply expose acute politicisation of the regulatory procedure.
A credible and predictable EU regulatory process is the only way to provide certainty for industry, farmers and the broad spectrum of glyphosate users.
The GTF considers this situation to be discriminatory and unacceptable. Ultimately, failure to renew the approval of glyphosate based on political considerations will only serve to seriously undermine the credibility of the EU legislative framework within an international context and will put European agriculture at competitive disadvantage.Decisions of this nature should be thoroughly science-based and not driven by political, media or NGO pressure.
The GTF calls on Member States to remedy this situation before it is too late by supporting the re-authorisation of glyphosate at the Appeals Committee which is expected to be convened in the near future.
Last update: 09 November 2017